TEVA PHARMACEUTICAL INDUSTRIES LIMITED Payments to Acquire Marketable Securities
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Payments to Acquire Marketable Securities of $221.00 million for the 3-month period ending 2010-03-31, per its 6-K filed 2010-05-04.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2010-05-04
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED payments to acquire marketable securities for the quarter ending 2010-03-31 was $221.00M, a 2355.56% increase year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED payments to acquire marketable securities for the quarter ending 2009-12-31 was $159.00M, a 45.17% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED payments to acquire marketable securities for the quarter ending 2009-09-30 was $234.00M, a 54.30% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED payments to acquire marketable securities for the quarter ending 2009-06-30 was $31.00M, a 95.13% decline year-over-year.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2010-03-31 | $221.00M 6-K · filed 2010-05-04 | $380.00M derived: sum of 2 quarters · filed 2010-05-04 | $614.00M derived: sum of 3 quarters · filed 2010-05-04 | $645.00M derived: sum of 4 quarters · filed 2010-05-04 |
| 2009-12-31 | $159.00M derived: 20-F 12 month − 6-K 9 month · filed 2010-02-22 | $393.00M derived: sum of 2 quarters · filed 2010-02-22 | $424.00M derived: sum of 3 quarters · filed 2010-02-22 | $433.00M 20-F · filed 2010-02-22 |
| 2009-09-30 | $234.00M derived: 6-K 9 month − 6-K 6 month · filed 2009-11-03 | $265.00M derived: sum of 2 quarters · filed 2009-11-03 | $274.00M 6-K · filed 2009-11-03 | $564.00M derived: sum of 4 quarters · filed 2010-05-04 |
| 2009-06-30 | $31.00M derived: 6-K 6 month − 6-K 3 month · filed 2009-07-29 | $40.00M 6-K · filed 2009-07-29 | $330.00M derived: sum of 3 quarters · filed 2010-05-04 | $842.00M derived: sum of 4 quarters · filed 2010-05-04 |
| 2009-03-31 | $9.00M 6-K · filed 2010-05-04 | $299.00M derived: sum of 2 quarters · filed 2010-05-04 | $811.00M derived: sum of 3 quarters · filed 2010-05-04 | $1.45B derived: sum of 4 quarters · filed 2010-05-04 |
| 2008-12-31 | $290.00M derived: 20-F 12 month − 6-K 9 month · filed 2010-02-22 | $802.00M derived: sum of 2 quarters · filed 2010-02-22 | $1.44B derived: sum of 3 quarters · filed 2010-02-22 | $2.15B 20-F · filed 2010-02-22 |
| 2008-09-30 | $512.00M derived: 6-K 9 month − 6-K 6 month · filed 2009-11-03 | $1.15B derived: sum of 2 quarters · filed 2009-11-03 | $1.86B 6-K · filed 2009-11-03 | |
| 2008-06-30 | $637.00M derived: 6-K 6 month − 6-K 3 month · filed 2009-07-29 | $1.35B 6-K · filed 2009-07-29 | ||
| 2008-03-31 | $716.00M 6-K · filed 2009-05-07 | |||
| 2007-12-31 | $5.30B 20-F · filed 2010-02-22 |